APLLTD — Alembic Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹149.41bn
- IN₹161.55bn
- IN₹73.45bn
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand
Brief: Alembic Pharma Q1 Consol Profit 1.73 Billion Rupees
Brief: Alembic Pharmaceuticals Receives US FDA Final Approval For Prucalopride Tablets, 1 Mg And 2 Mg
India's Alembic Pharma slips after US FDA warning letter
Brief: Alembic Pharmaceuticals Says FDA Issues Warning Letter For Bioequivalence Study; No Operational Restrictions Imposed
Brief: Alembic Pharmaceuticals Gets USFDA Final Approval For Dapsone Gel
Brief: Alembic Pharmaceuticals Receives USFDA Tentative Approval For Binimetinib Tablets, 45 Mg
Brief: Alembic Pharmaceuticals Receives USFDA Tentative Approval For Larotrectinib Capsules 25 Mg And 100 Mg
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Haloperidol Tablets
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Levothyroxine Sodium Tablets
India's Alembic Pharma falls after brokerage warns of margin pressure
Brief: Alembic Pharmaceuticals Passes ANVISA GMP Inspection For API-III Facility At Karakhadi
India's Alembic Pharma quarterly profit rises on strong U.S. generics demand
Brief: Alembic Pharmaceuticals March-Quarter Consol Profit 2.03 Billion Rupees
Brief: Alembic Pharmaceuticals Receives USFDA Establishment Inspection Report (Eir) For Its Injectable Facility
Brief: Alembic Pharmaceuticals Receives USFDA Tentative Approval For Darolutamide Tablets, 300 Mg